CARGO Therapeutics, Inc. Common Stock (CRGX) Stock
CRGX is no longer traded. CARGO Therapeutics, Inc. Common Stock was delisted from the Nasdaq in August 2025.
Prices on this page are historical; the last trade was August 18, 2025 at $4.47.
CARGO Therapeutics, Inc. Common Stock stock price history
CRGX final trading statistics
- Final close
- $4.47
- Final trading day
- Aug 18, 2025
- Market cap at delisting
- $216.19M
- Shares outstanding
- 48.36M
- Final 52-week range
- $3.00 – $25.45
- Avg. volume (final 3 mo.)
- 1,687,048
- All-time high (split-adj.)
- $32.23 · Mar 2024
- All-time low (split-adj.)
- $3.39 · Jan 2025
- Return since IPO
- -70.2%
- Beta
- —
- Book value / share
- $5.11
- Price / book
- 0.87
CARGO Therapeutics, Inc. Common Stock annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$167.5M | -$3.72 |
| FY2023 | $0.00 | -$98.1M | -$48.86 |
| FY2022 | $0.00 | -$41.0M | — |
| FY2021 | $0.00 | -$5.8M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About CARGO Therapeutics, Inc. Common Stock
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California. As of August 18, 2025, CARGO Therapeutics, Inc. operates as a subsidiary of Concentra Biosciences, LLC.
CARGO Therapeutics, Inc. Common Stock stock FAQ
What happened to CARGO Therapeutics, Inc. Common Stock stock?
CARGO Therapeutics, Inc. Common Stock stock was delisted from the Nasdaq. Its final close was $4.47 on August 18, 2025.
Is CRGX stock still trading?
No. CRGX was delisted from the Nasdaq in August 2025 and no longer trades on a U.S. exchange.
What was the last price of CRGX stock?
CRGX closed at $4.47 on its final trading day, August 18, 2025, for a market value of about $216.19M.
What were CARGO Therapeutics, Inc. Common Stock's revenue and earnings in its last full fiscal year?
CARGO Therapeutics, Inc. Common Stock reported revenue of $0.00 and net income of -$167.5M in fiscal 2024, its last full year as a public company.
When did CARGO Therapeutics, Inc. Common Stock go public?
CARGO Therapeutics, Inc. Common Stock stock began trading on November 10, 2023.